{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:29:57Z","timestamp":1791386997219,"version":"4.3.3"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ejogrb.2024.04.035","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T15:17:58Z","timestamp":1714231078000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Effects of individual drug and combination antiretroviral therapy on trophoblast proliferation"],"prefix":"10.1016","volume":"298","author":[{"given":"Sanelisiwe","family":"Nzuza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silindile I.","family":"Hadebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arieh A.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushi","family":"Matjila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2024.04.035_b0005","doi-asserted-by":"crossref","first-page":"e027344","DOI":"10.1136\/bmjopen-2018-027344","article-title":"Pregnancy outcome among HIV-infected women on different antiretroviral therapies in Ethiopia: a cohort study","volume":"9","author":"Ejigu","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0010","doi-asserted-by":"crossref","first-page":"7594306","DOI":"10.1155\/2016\/7594306","article-title":"Management of HIV infection during pregnancy in the United States: updated evidence-based recommendations and future potential practices","volume":"2016","author":"Rimawi","year":"2016","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0015","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJMoa1701666","article-title":"Birth outcomes for pregnant women with HIV using tenofovir-emtricitabine","volume":"378","author":"Rough","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1186\/s12879-018-3397-x","article-title":"Adverse effects of antiretroviral therapy in pregnant women infected with HIV in Brazil from 2000 to 2015: a cohort study","volume":"18","author":"Delicio","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0025","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1093\/cid\/ciaa805","article-title":"Pregnancy outcomes of women conceiving on antiretroviral therapy (ART) compared to those commenced on ART during pregnancy","volume":"73","author":"Theron","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0030","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4102\/sajhivmed.v18i1.776","article-title":"Adult antiretroviral therapy guidelines 2017","volume":"18","author":"Meintjes","year":"2017","journal-title":"South Afr J HIV Med"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0035","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7196\/SAMJ.2022.v112i10.16596","article-title":"Dolutegravir as first-line antiretroviral therapy in South Africa: beware the one-size-fits-all approach","volume":"112","author":"Bangalee","year":"2022","journal-title":"South Afr Med J"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1753495X15570994","article-title":"Prevention of mother-to-child transmission in South Africa: an ever-changing landscape","volume":"8","author":"Burton","year":"2015","journal-title":"Obstet Med"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0045","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/INF.0000000000003174","article-title":"Adverse pregnancy outcomes among HIV-positive women in the era of universal antiretroviral therapy remain elevated compared with HIV-negative women","volume":"40","author":"Tukei","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0050","doi-asserted-by":"crossref","first-page":"e172222","DOI":"10.1001\/jamapediatrics.2017.2222","article-title":"Comparative safety of antiretroviral treatment regimens in pregnancy","volume":"171","author":"Zash","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fgwh.2022.820759","article-title":"Preterm birth in women with HIV: the role of the placenta","volume":"3","author":"Ikumi","year":"2022","journal-title":"Front Glob Womens Health"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0060","doi-asserted-by":"crossref","first-page":"e0199555","DOI":"10.1371\/journal.pone.0199555","article-title":"Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy","volume":"13","author":"Stringer","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0065","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12884-015-0684-z","article-title":"Association between maternal HIV infection and low birth weight and prematurity: a meta-analysis of cohort studies","volume":"15","author":"Xiao","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0070","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/infdis\/jiv390","article-title":"Antiretroviral therapy and adverse pregnancy outcome: the elephant in the room?","volume":"213","author":"Mofenson","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/QAD.0b013e32834f3232","article-title":"Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn","volume":"26","author":"Hern\u00e0ndez","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0080","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1468-1293.2011.00945.x","article-title":"Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress","volume":"13","author":"Ross","year":"2012","journal-title":"HIV Med"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0085","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/infdis\/jis553","article-title":"Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana","volume":"206","author":"Chen","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jri.2005.12.001","article-title":"Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women","volume":"70","author":"Fiore","year":"2006","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/jiu393","article-title":"HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction","volume":"211","author":"Papp","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0100","doi-asserted-by":"crossref","first-page":"e31580","DOI":"10.1371\/journal.pone.0031580","article-title":"High prevalence of hypertension and placental insufficiency, but no in utero HIV transmission, among women on HAART with stillbirths in Botswana","volume":"7","author":"Shapiro","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0105","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.1038\/s41598-018-24680-w","article-title":"HIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation","volume":"8","author":"Mohammadi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.thromres.2004.06.038","article-title":"Growth and function of the normal human placenta","volume":"114","author":"Gude","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0115","doi-asserted-by":"crossref","first-page":"20140066","DOI":"10.1098\/rstb.2014.0066","article-title":"The placenta: a multifaceted, transient organ","volume":"370","author":"Burton","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0120","first-page":"S35","article-title":"Development and hormonal functions of the human placenta","volume":"47","author":"Guibourdenche","year":"2009","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5830\/CVJA-2016-009","article-title":"Pre-eclampsia: its pathogenesis and pathophysiology","volume":"27","author":"Gathiram","year":"2016","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0130","doi-asserted-by":"crossref","first-page":"S895","DOI":"10.1016\/j.ajog.2020.09.026","article-title":"Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia","volume":"226","author":"Staff","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0135","doi-asserted-by":"crossref","first-page":"20140070","DOI":"10.1098\/rstb.2014.0070","article-title":"The role of invasive trophoblast in implantation and placentation of primates","volume":"370","author":"Carter","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0140","first-page":"e137","article-title":"Regulation of trophoblast invasion: the role of matrix metalloproteinases","volume":"5","author":"Zhu","year":"2012","journal-title":"Rev Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0145","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.3389\/fimmu.2018.02597","article-title":"Regulation of placental extravillous trophoblasts by the maternal uterine environment","volume":"9","author":"Pollheimer","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0150","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/693157","article-title":"The possible role of extravillous trophoblast-derived exosomes on the uterine spiral arterial remodeling under both normal and pathological conditions","volume":"2014","author":"Salomon","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0155","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/humupd\/dmaa017","article-title":"Investigation of human trophoblast invasion in vitro","volume":"26","author":"Abbas","year":"2020","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0160","doi-asserted-by":"crossref","first-page":"S803","DOI":"10.1016\/j.ajog.2017.11.575","article-title":"A placenta clinic approach to the diagnosis and management of fetal growth restriction","volume":"218","author":"Kingdom","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0165","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/bdd.1794","article-title":"Pharmacokinetic profiling of efavirenz\u2013emtricitabine\u2013tenofovir fixed dose combination in pregnant and non-pregnant rats","volume":"33","author":"Nirogi","year":"2012","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0170","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1128\/AAC.00893-07","article-title":"Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy","volume":"51","author":"Saitoh","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0175","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jcmm.12935","article-title":"Mitochondrial toxicity and caspase activation in HIV pregnant women","volume":"21","author":"Hernandez","year":"2017","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/hep.23647","article-title":"Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells","volume":"52","author":"Blas-Garc\u00eda","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0185","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1749-6632.2000.tb05498.x","article-title":"Antiretroviral pharmacology in pregnant women and their newborns","volume":"918","author":"Mirochnick","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0190","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1128\/AAC.01523-08","article-title":"Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women","volume":"53","author":"Yeh","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0195","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.fertnstert.2011.05.094","article-title":"Human immunodeficiency virus\/acquired immunodeficiency syndrome and infertility: emerging problems in the era of highly active antiretrovirals","volume":"96","author":"Kushnir","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2016.07.041","article-title":"Naringin protects against HIV-1 protease inhibitor-induced pancreatic \u03b2-cell dysfunction and apoptosis","volume":"437","author":"Nzuza","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ejogrb.2024.04.035_b0205","first-page":"163","article-title":"Trophoblast invasion and placentation: molecular mechanisms and regulation","volume":"88","author":"van den Br\u00fble","year":"2005","journal-title":"Chem Immunol Allergy"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524002100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524002100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T01:14:29Z","timestamp":1718241269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211524002100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":41,"alternative-id":["S0301211524002100"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.04.035","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of individual drug and combination antiretroviral therapy on trophoblast proliferation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}